<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774579</url>
  </required_header>
  <id_info>
    <org_study_id>GHD1</org_study_id>
    <nct_id>NCT00774579</nct_id>
  </id_info>
  <brief_title>The Effect of Growth Hormone Replacement on Liver Fat</brief_title>
  <official_title>Growth Hormone Replacement in Adults With Growth Hormone Deficiency (GHD) - The Effect on Liver Fat.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will examine a cohort of growth hormone deficient adults starting growth hormone (GH)
      replacement. The purpose of this study is to determine whether GH replacement reduces the fat
      content of the liver.

      To compare the results we will include growth hormone deficient patients who do not start GH
      replacement as controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adults with untreated growth hormone deficiency (GHD), a condition mostly due to pituitary
      disease, often show metabolic features similar to those described in the 'metabolic
      syndrome'. Growth hormone (GH) replacement has been shown to reverse many of these
      unfavorable changes, with a particular evident reduction of visceral fat. In recent years, a
      strong correlation between fat accumulation in the liver and features of the metabolic
      syndrome (particularly visceral fat) has been identified, and 'fatty liver' is now being
      referred as the hepatic feature of the 'metabolic syndrome'. The effect of GH replacement on
      liver fat, however, has never been systematically studied.

      We will assess 15 patients with GHD before and 6 months after starting GH replacement. We
      will also assess 15 control patients with GHD but who don't go on GH replacement for various
      reasons.

      Liver fat will be assessed using MR spectroscopy. Changes in liver fat will be correlated to
      changes in insulin sensitivity and changes in various inflammatory markers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intrahepatocellular Lipid (IHCL) Content</measure>
    <time_frame>6 months</time_frame>
    <description>IHCL content determined by proton magnetic resonance spectroscopy (1H MRS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Adipose Tissue</measure>
    <time_frame>6 months</time_frame>
    <description>total adipose tissue assessed by MRI scan</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Growth Hormone, Recombinant</condition>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma, serum, leucocytes, 24-hour urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from the endocrine clinics of Imperial College Healthcare NHS
        Trust.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-70 years of age

          -  Growth hormone deficiency, with (cohort 1) or without (cohort 2) planned growth
             hormone (GH) replacement

          -  clinically stable

        Exclusion Criteria:

          -  known hepatic disease

          -  Acromegaly

          -  Diabetes mellitus

          -  growth hormone replacement within the last 12 months

          -  cushing's disease, if not cured for at least 12 months

          -  any contraindication to MR studies as set out in the MR safety questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabian A Meienberg, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen Robinson, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeremy Cox, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian Godsland, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jimmy Bell, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Desmond G Johnston, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon Taylor-Robinson, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emma Hatfield, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Yee, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinology &amp; Metabolic Medicine, Imperial College</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <results_first_submitted>April 29, 2019</results_first_submitted>
  <results_first_submitted_qc>April 29, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 12, 2019</results_first_posted>
  <last_update_submitted>April 29, 2019</last_update_submitted>
  <last_update_submitted_qc>April 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>growth hormone</keyword>
  <keyword>growth hormone deficiency</keyword>
  <keyword>liver fat</keyword>
  <keyword>liver steatosis</keyword>
  <keyword>growth hormone replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between April 2008 and April 2009 adult hypopituitary patients with untreated GHD were identified and recruited at the endocrine clinics of Imperial College Healthcare NHS Trust.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>GH Replacement</title>
          <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GH Replacement</title>
          <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" spread="8"/>
                    <measurement group_id="B2" value="52" spread="9"/>
                    <measurement group_id="B3" value="52" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intrahepatocellular Lipid (IHCL) Content</title>
        <description>IHCL content determined by proton magnetic resonance spectroscopy (1H MRS).</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GH Replacement</title>
            <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
          </group>
        </group_list>
        <measure>
          <title>Intrahepatocellular Lipid (IHCL) Content</title>
          <description>IHCL content determined by proton magnetic resonance spectroscopy (1H MRS).</description>
          <units>% change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.63" spread="4.53"/>
                    <measurement group_id="O2" value="0.11" spread="1.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Adipose Tissue</title>
        <description>total adipose tissue assessed by MRI scan</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GH Replacement</title>
            <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Adipose Tissue</title>
          <description>total adipose tissue assessed by MRI scan</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="3.2"/>
                    <measurement group_id="O2" value="0.24" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>GH Replacement</title>
          <description>Patients with growth hormone (GH) deficiency starting GH replacement.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patients with growth hormone (GH) deficiency not starting GH replacement.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Desmond Johnston</name_or_title>
      <organization>Imperial College Healthcare London</organization>
      <phone>020 3312 1253</phone>
      <email>desmond.johnston@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

